Sfoglia per Titolo
Pk nella patologia della superficie ocualre
2012-01-01 Rama, P
PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD
2020-01-01 Gilardi, Daniela; Gabbiadini, Roberto; Allocca, Mariangela; Correale, Carmen; Fiorino, Gionata; Furfaro, Federica; Zilli, Alessandra; Peyrin-Biroulet, Laurent; Danese, Silvio
PKAN hiPS-Derived Astrocytes Show Impairment of Endosomal Trafficking: A Potential Mechanism Underlying Iron Accumulation.
2022-01-01 Ripamonti, M; Santambrogio, P; Racchetti, G; Cozzi, A; Di Meo, I; Tiranti, V; Levi, S.
PKC epsilon INVOLVEMENT IN Th17 IN VITRO DIFFERENTIATION: IMPLICATIONS IN PSORIASIS PATHOGENESIS
2016-01-01 Galli, Daniela; Martini, Silvia; Pozi, G; Masselli, Elena; Carubbi, Cecilia; Gobbi, Giuliana; Mirandola, Prisco; Vitale, Marco
PKC Proteins and Muscular Dystrophy
2018-01-01 Gobbi, G; Galli, D; Carubbi, C; Neri, Lm; Masselli, E; Pozzi, G; Vitale, M; Mirandola, P
PKC-redox axis in myogenic differentiation
2019-01-01 Pozzi, Giulia; Presta, Valentina; Galli, Daniela; Masselli, Elena; Gobbi, Giuliana; Mirandola, Prisco; Vitale, Marco; Carubbi, Cecilia.
PKCepsilon expression is requie during proplatelet formation in murine model
2012-01-01 Gobbi, Giuliana; Carubbi, Cecilia; Galli, Daniela; DI MARCANTONIO, D; Bucci, Giovanna; Masselli, Elena; Queirolo, Valeria; Mirandola, Prisco; Vaccarezza, M; Italiano, Je; Vitale, Marco
PKCε as a novel promoter of skeletal muscle differentiation and regeneration
2015-01-01 DI MARCANTONIO, Daniela; Galli, Daniela; Carubbi, Cecilia; Gobbi, Giuliana; Queirolo, Valeria; Martini, Silvia; Merighi, S.; Vaccarezza, M.; Maffulli, N.; Sykes, S. M.; Vitale, Marco; Mirandola, Prisco
PKCε Controls Mitotic Progression by Regulating Centrosome Migration and Mitotic Spindle Assembly
2018-01-01 Martini, Silvia; Soliman, Tanya; Gobbi, Giuliana; Mirandola, Prisco; Carubbi, Cecilia; Masselli, Elena; Pozzi, Giulia; Parker, Peter J; Vitale, Marco
PKCε dependent signalling in cardiac differentiation
2013-01-01 Galli, Daniela; Gobbi, Giuliana; Carubbi, Cecilia; DI MARCANTONIO, Daniela; Masselli, Elena; Mirandola, Prisco; Vitale, M.
PKCε is a negative regulator of PVAT-derived vessel formation
2015-01-01 Galli, Daniela; Carubbi, Cecilia; Masselli, Elena; Corradi, Domenico; DEI CAS, Alessandra; Nouvenne, Antonio; Bucci, Giovanna; Arcari, Maria Luisa; Mirandola, Prisco; Vitale, Marco; Gobbi, Giuliana
PKCε promotes human Th17 differentiation: Implications in the pathophysiology of psoriasis
2018-01-01 Martini, Silvia; Pozzi, Giulia; Carubbi, Cecilia; Masselli, Elena; Galli, Daniela; Nuzzo, Sergio Di; Banchini, Antonio; Gobbi, Giuliana; Vitale, Marco; Mirandola, Prisco
PKCε regulates vessel formation by peri-vascular adipose tissue (PVAT) cells
2014-01-01 Galli, Daniela; Carubbi, Cecilia; Masselli, Elena; Queirolo, Valeria; Bucci, Giovanna; Mirandola, Prisco; Gobbi, Giuliana; Vitale, Marco
PKD1 and PKD2 gene variants in Italian patients affected by autosomal dominant polycystic kidney disease (ADPKD).
2010-01-01 Carrera, P; Rigo, F; Montrasio, C; Calzavara, S; Palmieri, L; Messa, P; Edefonti, A; Scolari, F; Manunta, Paolo; Boletta, A; Ferrari, Maurizio
PKNOX1, a gene encoding PREP1, a new regulator of Pbx activity, maps on human chromosome 21q22.3 and murine chromosome 17B/C
1998-01-01 Berthelsen, J; Viggiano, L; Schulz, H; Ferretti, E; Consalez, GIAN GIACOMO; Rocchi, M; Blasi, F.
PL-7 positive antisynthetase syndrome and pulmonary hypertension
2013-01-01 Foris, V; Kovacs, G; MATUCCI CERINIC, Marco; Olschewski, H.
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia
2021-01-01 Clerici, D.; Oltolini, C.; Greco, R.; Ripa, M.; Giglio, F.; Mastaglio, S.; Lorentino, F.; Pavesi, F.; Farina, F.; Liberatore, C.; Castiglion, B.; Tassan Din, C.; Bernardi, M.; Corti, C.; Peccatori, J.; Scarpellini, P.; Ciceri, F.; Castagna, A.
The place of ‘unreasonable’ people beyond Rawls
2013-01-01 Sala, Roberta
Placebo-controlled multicentre randomised trial of interferon ß-1b in treatment of secondary progressive multiple sclerosis
1998-01-01 EUROPEAN STUDY GROUP ON INTERFERON ß., 1b IN SECONDARY PROGRESSIVE MS; Comi, Giancarlo
Placebo-controlled trial of oral laquinimod for multiple sclerosis.
2012-01-01 Comi, Giancarlo; Jeffery, D; Kappos, L; Montalban, X; Boyko, A; Rocca, Ma; Filippi, Massimo; for the ALLEGRO Study, Group
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Pk nella patologia della superficie ocualre | 1-gen-2012 | Rama, P | |
| PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD | 1-gen-2020 | Gilardi, Daniela; Gabbiadini, Roberto; Allocca, Mariangela; Correale, Carmen; Fiorino, Gionata; Furfaro, Federica; Zilli, Alessandra; Peyrin-Biroulet, Laurent; Danese, Silvio | |
| PKAN hiPS-Derived Astrocytes Show Impairment of Endosomal Trafficking: A Potential Mechanism Underlying Iron Accumulation. | 1-gen-2022 | Ripamonti, M; Santambrogio, P; Racchetti, G; Cozzi, A; Di Meo, I; Tiranti, V; Levi, S. | |
| PKC epsilon INVOLVEMENT IN Th17 IN VITRO DIFFERENTIATION: IMPLICATIONS IN PSORIASIS PATHOGENESIS | 1-gen-2016 | Galli, Daniela; Martini, Silvia; Pozi, G; Masselli, Elena; Carubbi, Cecilia; Gobbi, Giuliana; Mirandola, Prisco; Vitale, Marco | |
| PKC Proteins and Muscular Dystrophy | 1-gen-2018 | Gobbi, G; Galli, D; Carubbi, C; Neri, Lm; Masselli, E; Pozzi, G; Vitale, M; Mirandola, P | |
| PKC-redox axis in myogenic differentiation | 1-gen-2019 | Pozzi, Giulia; Presta, Valentina; Galli, Daniela; Masselli, Elena; Gobbi, Giuliana; Mirandola, Prisco; Vitale, Marco; Carubbi, Cecilia. | |
| PKCepsilon expression is requie during proplatelet formation in murine model | 1-gen-2012 | Gobbi, Giuliana; Carubbi, Cecilia; Galli, Daniela; DI MARCANTONIO, D; Bucci, Giovanna; Masselli, Elena; Queirolo, Valeria; Mirandola, Prisco; Vaccarezza, M; Italiano, Je; Vitale, Marco | |
| PKCε as a novel promoter of skeletal muscle differentiation and regeneration | 1-gen-2015 | DI MARCANTONIO, Daniela; Galli, Daniela; Carubbi, Cecilia; Gobbi, Giuliana; Queirolo, Valeria; Martini, Silvia; Merighi, S.; Vaccarezza, M.; Maffulli, N.; Sykes, S. M.; Vitale, Marco; Mirandola, Prisco | |
| PKCε Controls Mitotic Progression by Regulating Centrosome Migration and Mitotic Spindle Assembly | 1-gen-2018 | Martini, Silvia; Soliman, Tanya; Gobbi, Giuliana; Mirandola, Prisco; Carubbi, Cecilia; Masselli, Elena; Pozzi, Giulia; Parker, Peter J; Vitale, Marco | |
| PKCε dependent signalling in cardiac differentiation | 1-gen-2013 | Galli, Daniela; Gobbi, Giuliana; Carubbi, Cecilia; DI MARCANTONIO, Daniela; Masselli, Elena; Mirandola, Prisco; Vitale, M. | |
| PKCε is a negative regulator of PVAT-derived vessel formation | 1-gen-2015 | Galli, Daniela; Carubbi, Cecilia; Masselli, Elena; Corradi, Domenico; DEI CAS, Alessandra; Nouvenne, Antonio; Bucci, Giovanna; Arcari, Maria Luisa; Mirandola, Prisco; Vitale, Marco; Gobbi, Giuliana | |
| PKCε promotes human Th17 differentiation: Implications in the pathophysiology of psoriasis | 1-gen-2018 | Martini, Silvia; Pozzi, Giulia; Carubbi, Cecilia; Masselli, Elena; Galli, Daniela; Nuzzo, Sergio Di; Banchini, Antonio; Gobbi, Giuliana; Vitale, Marco; Mirandola, Prisco | |
| PKCε regulates vessel formation by peri-vascular adipose tissue (PVAT) cells | 1-gen-2014 | Galli, Daniela; Carubbi, Cecilia; Masselli, Elena; Queirolo, Valeria; Bucci, Giovanna; Mirandola, Prisco; Gobbi, Giuliana; Vitale, Marco | |
| PKD1 and PKD2 gene variants in Italian patients affected by autosomal dominant polycystic kidney disease (ADPKD). | 1-gen-2010 | Carrera, P; Rigo, F; Montrasio, C; Calzavara, S; Palmieri, L; Messa, P; Edefonti, A; Scolari, F; Manunta, Paolo; Boletta, A; Ferrari, Maurizio | |
| PKNOX1, a gene encoding PREP1, a new regulator of Pbx activity, maps on human chromosome 21q22.3 and murine chromosome 17B/C | 1-gen-1998 | Berthelsen, J; Viggiano, L; Schulz, H; Ferretti, E; Consalez, GIAN GIACOMO; Rocchi, M; Blasi, F. | |
| PL-7 positive antisynthetase syndrome and pulmonary hypertension | 1-gen-2013 | Foris, V; Kovacs, G; MATUCCI CERINIC, Marco; Olschewski, H. | |
| The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia | 1-gen-2021 | Clerici, D.; Oltolini, C.; Greco, R.; Ripa, M.; Giglio, F.; Mastaglio, S.; Lorentino, F.; Pavesi, F.; Farina, F.; Liberatore, C.; Castiglion, B.; Tassan Din, C.; Bernardi, M.; Corti, C.; Peccatori, J.; Scarpellini, P.; Ciceri, F.; Castagna, A. | |
| The place of ‘unreasonable’ people beyond Rawls | 1-gen-2013 | Sala, Roberta | |
| Placebo-controlled multicentre randomised trial of interferon ß-1b in treatment of secondary progressive multiple sclerosis | 1-gen-1998 | EUROPEAN STUDY GROUP ON INTERFERON ß., 1b IN SECONDARY PROGRESSIVE MS; Comi, Giancarlo | |
| Placebo-controlled trial of oral laquinimod for multiple sclerosis. | 1-gen-2012 | Comi, Giancarlo; Jeffery, D; Kappos, L; Montalban, X; Boyko, A; Rocca, Ma; Filippi, Massimo; for the ALLEGRO Study, Group |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile